Avacincaptad pegol (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Avacincaptad pegol" in English language version.

refsWebsite
Global rank English rank
1st place
1st place
4th place
4th place
447th place
338th place
406th place
258th place
5,893rd place
3,320th place
2nd place
2nd place
11th place
8th place
102nd place
76th place

doi.org

fda.gov

fda.gov

accessdata.fda.gov

figshare.com

handle.net

hdl.handle.net

nih.gov

dailymed.nlm.nih.gov

  • "Izervay- avacincaptad pegol injection". DailyMed. 9 August 2023. Archived from the original on 26 August 2023. Retrieved 25 August 2023.

pubmed.ncbi.nlm.nih.gov

prnewswire.com

semanticscholar.org

api.semanticscholar.org

web.archive.org

  • "Izervay- avacincaptad pegol injection". DailyMed. 9 August 2023. Archived from the original on 26 August 2023. Retrieved 25 August 2023.
  • "Novel Drug Approvals for 2023". U.S. Food and Drug Administration (FDA). 18 August 2023. Archived from the original on 21 January 2023. Retrieved 25 August 2023. Public Domain This article incorporates text from this source, which is in the public domain.
  • "Iveric Bio Receives U.S. FDA Approval for Izervay (avacincaptad pegol intravitreal solution), a New Treatment for Geographic Atrophy" (Press release). Astellas Pharma Inc. 4 August 2023. Archived from the original on 26 August 2023. Retrieved 25 August 2023 – via PR Newswire.
  • Kang C (October 2023). "Avacincaptad Pegol: First Approval". Drugs. 83 (15): 1447–1453. doi:10.1007/s40265-023-01948-8. PMID 37814173. S2CID 263801918. Archived from the original on 27 April 2024. Retrieved 18 December 2023.
  • "Drug Approval Package: Izervay". U.S. Food and Drug Administration (FDA). 1 September 2023. Archived from the original on 20 November 2023. Retrieved 20 November 2023.